Effects of obesity treatments on bone mineral density, bone turnover and fracture risk in adults with overweight or obesity

Hormone Molecular Biology and Clinical Investigation

Volumn 28, Issue 3, 2016, Pages 133-149

  Harper, Claudia ^a   Pattinson, Andrea L ^a   Fernando, Hamish A ^a   Zibellini, Jessica ^a   Seimon, Radhika V ^a   Sainsbury, Amanda ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

bariatric surgery; diet reducing; glucagon like peptide 1 receptor agonists; orlistat; weight loss

Indexed keywords

CALCIUM; GLUCAGON LIKE PEPTIDE 1 RECEPTOR AGONIST; NEUROPEPTIDE Y; OSTEOCALCIN; PROTEIN; SCLEROSTIN; TETRAHYDROLIPSTATIN; VITAMIN D;

BARIATRIC SURGERY; BONE DENSITY; BONE MASS; BONE METABOLISM; BONE MINERAL; BONE STRUCTURE; BONE TURNOVER; CALCIUM INTAKE; COMPUTER ASSISTED TOMOGRAPHY; DIET RESTRICTION; DUAL ENERGY X RAY ABSORPTIOMETRY; FOLLOW UP; FRACTURE; GASTRIC BANDING; HUMAN; LIFESTYLE MODIFICATION; LONG TERM CARE; NUTRITIONAL STATUS; OBESITY; OSSIFICATION; OSTEOLYSIS; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROTEIN INTAKE; RESISTANCE TRAINING; REVIEW; RISK; VITAMIN INTAKE; WEIGHT BEARING; WEIGHT LOSS PROGRAM; WEIGHT REDUCTION; ADULT; BONE REMODELING; OVERWEIGHT; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADULT; BONE DENSITY; BONE REMODELING; FRACTURES, BONE; HUMANS; OBESITY; OVERWEIGHT;

EID: 85001819624     PISSN: 18681883     EISSN: 18681891     Source Type: Journal    
DOI: 10.1515/hmbci-2016-0025     Document Type: Review

References (117)

1. Ng M, Fleming T, Robinson M, Thomson B, Graetz N, Margono C, Mullany EC, Biryukov S, Abbafati C, Abera SF, Abraham JP, Abu- Rmeileh NM, Achoki T, AlBuhairan FS, Alemu ZA, Alfonso R, Ali MK, Ali R, Guzman NA, Ammar W, Anwari P, Banerjee A, Barquera S, Basu S, Bennett DA, Bhutta Z, Blore J, Cabral N, Nonato IC, Chang JC, Chowdhury R, Courville KJ, Criqui MH, Cundiff DK, Dabhadkar KC, Dandona L, Davis A, Dayama A, Dharmaratne SD, Ding EL, Durrani AM, Esteghamati A, Farzadfar F, Fay DF, Feigin VL, Flaxman A, Forouzanfar MH, Goto A, Green MA, Gupta R, Hafezi-Nejad N, Hankey GJ, Harewood HC, Havmoeller R, Hay S, Hernandez L, Husseini A, Idrisov BT, Ikeda N, Islami F, Jahangir E, Jassal SK, Jee SH, Jeffreys M, Jonas JB, Kabagambe EK, Khalifa SE, Kengne AP, Khader YS, Khang YH, Kim D, Kimokoti RW, Kinge JM, Kokubo Y, Kosen S, Kwan G, Lai T, Leinsalu M, Li Y, Liang X, Liu S, Logroscino G, Lotufo PA, Lu Y, Ma J, Mainoo NK, Mensah GA, Merriman TR, Mokdad AH, Moschandreas J, Naghavi M, Naheed A, Nand D, Narayan KM, Nelson EL, Neuhouser ML, Nisar MI, Ohkubo T, Oti SO, Pedroza A, Prabhakaran D, Roy N, Sampson U, Seo H, Sepanlou SG, Shibuya K, Shiri R, Shiue I, Singh GM, Singh JA, Skirbekk V, Stapelberg NJ, Sturua L, Sykes BL, Tobias M, Tran BX, Trasande L, Toyoshima H, van de Vijver S, Vasankari TJ, Veerman JL, Velasquez-Melendez G, Vlassov VV, Vollset SE, Vos T, Wang C, Wang X, Weiderpass E, Werdecker A, Wright JL, Yang YC, Yatsuya H, Yoon J, Yoon SJ, Zhao Y, Zhou M, Zhu S, Lopez AD, Murray CJ, Gakidou E. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980- 2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2014;384:766-81.
2. Bales CW, Buhr G. Is obesity bad for older persons? A systematic review of the pros and cons of weight reduction in later life. J Am Med Dir Assoc 2008;9:302-12.
3. Markovic TP, Natoli SJ. Paradoxical nutritional deficiency in overweight and obesity: the importance of nutrient density. Med J Aust 2009;190:149-51.
4. Stein EM, Strain G, Sinha N, Ortiz D, Pomp A, Dakin G, McMahon DJ, Bockman R, Silverberg SJ. Vitamin D insufficiency prior to bariatric surgery: risk factors and a pilot treatment study. Clin Endocrinol 2009;71:176-83.
5. Grethen E, Hill KM, Jones R, Cacucci BM, Gupta CE, Acton A, Considine RV, Peacock M. Serum leptin, parathyroid hormone, 1, 25-dihydroxyvitamin D, fibroblast growth factor 23, bone alkaline phosphatase, and sclerostin relationships in obesity. J Clin Endocrinol Metab 2012;97:1655-62.
6. Hsu Y-H, Venners SA, Terwedow HA, Feng Y, Niu T, Li Z, Laird N, Brain JD, Cummings SR, Bouxsein ML, Rosen CJ, Xu X. Relation of body composition, fat mass, and serum lipids to osteoporotic fractures and bone mineral density in Chinese men and women. Am J Clin Nutr 2006;83:146-54.
7. Compston JE, Watts NB, Chapurlat R, Cooper C, Boonen S, Greenspan S, Pfeilschifter J, Silverman S, Diez-Perez A, Lindsay R, Saag KG, Netelenbos JC, Gehlbach S, Hooven FH, Flahive J, Adachi JD, Rossini M, Lacroix AZ, Roux C, Sambrook PN, Siris ES, Glow I. Obesity is not protective against fracture in postmenopausal women: GLOW. Am J Med 2011;124: 1043-50.
8. Nielson CM, Srikanth P, Orwoll ES. Obesity and fracture in men and women: an epidemiologic perspective. J Bone Miner Res 2012;27:1-10.
9. Gonnelli S, Caffarelli C, Nuti R. Obesity and fracture risk. Clin Cases Miner Bone Metab 2014;11:9-14.
10. Brzozowska MM, Sainsbury A, Eisman JA, Baldock PA, Center JR. Bariatric surgery and bone loss: do we need to be concerned? Clin Rev Bone Miner Metab 2014;12:207-27.
11. Brzozowska MM, Sainsbury A, Eisman JA, Baldock PA, Center JR. Bariatric surgery, bone loss, obesity and possible mechanisms. Obes Rev 2013;14:52-67.
12. Shapses SA, Sukumar D. Bone metabolism in obesity and weight loss. Annu Rev Nutr 2012;32:287-309.
13. Mpalaris V, Anagnostis P, Goulis DG, Iakovou I. Complex association between body weight and fracture risk in postmenopausal women. Obes Rev 2015;16:225-33.
14. Cipriani C, Pepe J, Piemonte S, Colangelo L, Cilli M, Minisola S. Vitamin D and its relationship with obesity and muscle. Int J Endocrinol 2014;2014:841248.
15. Halade GV, El Jamali A, Williams PJ, Fajardo RJ, Fernandes G. Obesity-mediated inflammatory microenvironment stimulates osteoclastogenesis and bone loss in mice. Exp Gerontol 2011;46:43-52.
16. Koster A, Penninx BW, Newman AB, Visser M, van Gool CH, Harris TB, van Eijk JT, Kempen GI, Brach JS, Simonsick EM, Houston DK, Tylavsky FA, Rubin SM, Kritchevsky SB. Lifestyle factors and incident mobility limitation in obese and non-obese older adults. Obesity (Silver Spring) 2007;15:3122-32.
17. Madigan M, Rosenblatt NJ, Grabiner MD. Obesity as a factor contributing to falls by older adults. Curr Obes Rep 2014;3: 348-54.
18. Ren J, Waclawczyk A, Hartfield D, Yu S, Kuang X, Zhang H, Alamgir H. Analysis of fall injuries by body mass index. South Med J 2014;107:294-300.
19. Manini TM, Clark BC, Nalls MA, Goodpaster BH, Ploutz-Snyder LL, Harris TB. Reduced physical activity increases intermuscular adipose tissue in healthy young adults. Am J Clin Nutr 2007;85:377-84.
20. Addison O, Marcus RL, Lastayo PC, Ryan AS. Intermuscular fat: a review of the consequences and causes. Int J Endocrinol 2014;2014:309570.
21. Bouxsein ML, Szulc P, Munoz F, Thrall E, Sornay-Rendu E, Delmas PD. Contribution of trochanteric soft tissues to fall force estimates, the factor of risk, and prediction of hip fracture risk. J Bone Miner Res 2007;22:825-31.
22. Compston JE, Flahive J, Hooven FH, Anderson FA, Jr., Adachi JD, Boonen S, Chapurlat RD, Cooper C, Diez-Perez A, Greenspan SL, LaCroix AZ, Lindsay R, Netelenbos JC, Pfeilschifter J, Roux C, Saag KG, Silverman S, Siris ES, Watts NB, Gehlbach SH. Obesity, health-care utilization, and health-related quality of life after fracture in postmenopausal women: Global Longitudinal Study of Osteoporosis in Women (GLOW). Calcif Tissue Int 2014;94:223-31.
23. Fernando HA, Zibellini J, Hsu MH, Seimon RV, Nguyen AD, Sainsbury A. The neuropeptide Y-ergic system: potential therapeutic target against bone loss with obesity treatments. Expert Rev Endocrinol Metab 2015;10:177-91.
24. Ross MH, Pawlina W. Histology: a text and atlas. Philadelphia: Lippincott Williams & Wilkins, 2010.
25. Kini U, Nandeesh BN. Histology of bone formation, remodeling, and metabolism. In: Fogelman I, Gnanasegaran G, van der Wall H, editors. Germany: Springer Berlin Heidelberg, 2012.
26. Coates P. Bone turnover markers. Aust Fam Physician 2013;42:285-7.
27. Parfitt AM. What is the normal rate of bone remodeling? Bone 2004;35:1-3.
28. Little DG, Ramachandran M, Schindeler A. The anabolic and catabolic responses in bone repair. J Bone Joint Surg Br 2007;89:425-33.
29. Sims NA, Martin TJ. Coupling the activities of bone formation and resorption: a multitude of signals within the basic multicellular unit. Bonekey Rep 2014;3:481.
30. NIH Consensus Development Panel on Osteoporosis Prevention D, and Therapy. Osteoporosis prevention, diagnosis, and therapy. J Am Med Assoc 2001;285:785-95.
31. Toombs RJ, Ducher G, Shepherd JA, De Souza MJ. The impact of recent technological advances on the trueness and precision of DXA to assess body composition. Obesity (Silver Spring) 2012;20:30-9.
32. Knapp KM, Welsman JR, Hopkins SJ, Fogelman I, Blake GM. Obesity increases precision errors in dual-energy X-ray absorptiometry measurements. J Clin Densitom 2012;15:315-9.
33. Yu EW. Bone metabolism after bariatric surgery. J Bone Miner Res 2014;29:1507-18.
34. Zibellini J, Seimon RV, Lee CM, Gibson AA, Hsu MS, Shapses SA, Nguyen TV, Sainsbury A. Does diet-induced weight loss lead to bone loss in overweight or obese adults? A systematic review and meta-analysis of clinical trials. J Bone Miner Res 2015;30:2168-78.
35. Bolotin HH. DXA in vivo BMD methodology: an erroneous and misleading research and clinical gauge of bone mineral status, bone fragility, and bone remodelling. Bone 2007;41:138-54.
36. Blake GM, Fogelman I. How important are BMD accuracy errors for the clinical interpretation of DXA scans? J Bone Miner Res 2008;23:457-62.
37. Hunter GR, Plaisance EP, Fisher G. Weight loss and bone mineral density. Curr Opin Endocrinol Diabetes Obes 2014;21:358-62.
38. Leslie WD, Lix LM. Comparison between various fracture risk assessment tools. Osteoporos Int 2014;25:1-21.
39. Seabolt LA, Welch EB, Silver HJ. Imaging methods for analyzing body composition in human obesity and cardiometabolic disease. Ann N Y Acad Sci 2015;1353:41-59.
40. Kanis JA, McCloskey EV, Johansson H, Cooper C, Rizzoli R, Reginster JY. European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 2013;24:23-57.
41. Lee J, Vasikaran S. Current recommendations for laboratory testing and use of bone turnover markers in management of osteoporosis. Ann Lab Med 2012;32:105-12.
42. Wheater G, Elshahaly M, Tuck SP, Datta HK, van Laar JM. The clinical utility of bone marker measurements in osteoporosis. J Transl Med 2013;11:201.
43. Seibel MJ. Biochemical markers of bone turnover: part I: biochemistry and variability. Clin Biochem Rev 2005;26:97-122.
44. Chubb SA, Byrnes E, Manning L, Beilby JP, Ebeling PR, Vasikaran SD, Golledge J, Flicker L, Yeap BB. Reference intervals for bone turnover markers and their association with incident hip fractures in older men: the Health in Men study. J Clin Endocrinol Metab 2015;100:90-9.
45. Delmas PD, Christiansen C, Mann KG, Price PA. Bone Gla protein (osteocalcin) assay standardization report. J Bone Miner Res 1990;5:5-11.
46. Gorai I, Hosoda K, Chaki O, Taguchi Y, Nakayama M, Yoh K, Yamaji T, Minaguchi H. A heterogeneity in serum osteocalcin N-terminal fragments in Paget's disease: a comparison with other biochemical indices in pre- and postmenopause. Calcif Tissue Int 1998;63:459-65.
47. Page AE, Hayman AR, Andersson LM, Chambers TJ, Warburton MJ. Degradation of bone matrix proteins by osteoclast cathepsins. Int J Biochem 1993;25:545-50.
48. Qvist P, Christgau S, Pedersen BJ, Schlemmer A, Christiansen C. Circadian variation in the serum concentration of C-terminal telopeptide of type I collagen (serum CTx): effects of gender, age, menopausal status, posture, daylight, serum cortisol, and fasting. Bone 2002;31:57-61.
49. Buchwald H, Oien DM. Metabolic/bariatric surgery worldwide 2011. Obes Surg 2013;23:427-36.
50. Stein EM, Shonni J. Bone loss after bariatric surgery: causes, consequences, and management. Lancet Diabetes Endocrinol 2014;2:165-74.
51. Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K, Schoelles K. Bariatric surgery: a systematic review and meta-analysis. J Am Med Assoc 2004;292:1724-37.
52. Dixon JB, Nora E, Lambert EA, Schlaich MP, Lambert GW. Surgical approaches to the treatment of obesity. Nat Rev Gastroenterol Hepatol 2011;8:429-37.
53. Sinha N, Shieh A, Stein EM, Strain G, Schulman A, Pomp A, Gagner M, Dakin G, Christos P, Bockman RS. Increased PTH and 1.25(OH)2D levels associated with increased markers of bone turnover following bariatric surgery. Obesity (Silver Spring) 2011;19:2388-93.
54. Liu C, Wu D, Zhang JF, Xu D, Xu WF, Chen Y, Liu BY, Li P, Li L. Changes in bone metabolism in morbidly obese patients after bariatric surgery: a meta-analysis. Obes Surg 2016;26:91-7.
55. Ko B-J, Myung SK, Cho K-H, Park YG, Kim SG, Kim DH, Kim SM. Relationship between bariatric surgery and bone mineral density: a meta-analysis. Obes Surg 2016;26:1414-21.
56. Rodríguez-Carmona Y, López-Alavez FJ, González-Garay AG, Solís-Galicia C, Meléndez G, Serralde-Zúñiga AE. Bone mineral density after bariatric surgery. A systematic review. Int J Surg 2014;12:976-82.
57. von Mach MA, Stoeckli R, Bilz S, Kraenzlin M, Langer I, Keller U. Changes in bone mineral content after surgical treatment of morbid obesity. Metabolis 2004;53:918-21.
58. Pugnale N, Giusti V, Suter M, Zysset E, Heraief E, Gaillard RC, Burckhardt P. Bone metabolism and risk of secondary hyperparathyroidism 12 months after gastric banding in obese pre-menopausal women. Int J Obes Relat Metab Disord 2003;27:110-6.
59. Maghrabi AH. Two-year outcomes on bone density and fracture incidence in patients with T2DM randomized to bariatric surgery versus intensive medical therapy Bone Density in Diabetes After Bariatric Surgery. Obesity (Silver Spring) 2015;23:2344-8.
60. Fleischer J, Stein EM, Bessler M, Badia MD, Restuccia N, Olivero- Rivera L, McMahon DJ, Silverberg SJ. The decline in hip bone density after gastric bypass surgery is associated with extent of weight loss. J Clin Endo Metab 2008;93:3735-40.
61. Pluskiewicz W, Bužga M, Holéczy P, Bortlík L, Šmajstrla V, Adamczyk P. Bone mineral changes in spine and proximal femur in individual obese women after laparoscopic sleeve gastrectomy: a short-term study. Obes Surg 2012;22: 1068-76.
62. Giusti V, Gasteyger C, Suter M, Heraief E, Gaillard RC, Burckhardt P. Gastric banding induces negative bone remodelling in the absence of secondary hyperparathyroidism: potential role of serum C telopeptides for follow-up. Int J Obes Relat Metab Disord 2005;29:1429-35.
63. Vilarrasa N, San José P, García I, Gómez-Vaquero C, Medina Miras P, Gordejuela AG, Masdevall C, Pujol J, Soler J, Gómez JM. Evaluation of bone mineral density loss in morbidly obese women after gastric bypass: 3-year follow-up. Obes Surg 2010;21:465-72.
64. Zhu K, Hunter M, James A, Lim EM, Walsh JP. Associations between body mass index, lean and fat body mass and bone mineral density in middle-aged Australians: the Busselton Healthy Ageing Study. Bone 2015;74:146-52.
65. Johnson JM, Maher JW, Samuel I, Heitshusen D, Doherty C, Downs RW. Effects of gastric bypass procedures on bone mineral density, calcium, parathyroid hormone, and vitamin D. J Gastrointest Surg 2005;9:1106-11.
66. Lu C-W, Chang Y-K, Chang H-H, Kuo C-S, Huang C-T, Hsu C-C, Huang K-C. Fracture risk after bariatric surgery: a 12-year nationwide cohort study. Medicine 2015;94:e2087.
67. Nakamura KM, Haglind EG, Clowes JA, Achenbach SJ, Atkinson EJ, Melton LJ, Kennel KA. Fracture risk following bariatric surgery: a population-based study. Osteoporos Int 2014;25:151-8.
68. Lalmohamed A, de Vries F, Bazelier MT, Cooper A, van Staa TP, Cooper C, Harvey NC. Risk of fracture after bariatric surgery in the United Kingdom: population based, retrospective cohort study. Br Med J 2012;345:e5085.
69. Ott MT, Fanti P, Malluche HH, Ryo UY, Whaley FS, Strodel WE, Colacchio TA. Biochemical evidence of metabolic bone disease in women following Roux-Y gastric bypass for morbid obesity. Obes Surg 1992;2:341-8.
70. Bruno C, Fulford AD, Potts JR, McClintock R, Jones R, Cacucci BM, Gupta CE, Peacock M, Considine RV. Serum markers of bone turnover are increased at six and 18 months after Roux-En-Y bariatric surgery: correlation with the reduction in leptin. J Clin Endo Metab 2010;95:159-66.
71. Heber D, Greenway FL, Kaplan LM, Livingston E, Salvador J, Still C. Endocrine and nutritional management of the post-bariatric surgery patient: an endocrine society clinical practice guideline. J Clin Endo Metab 2010;95:4823-43.
72. Yu EW, Bouxsein ML, Roy AE, Baldwin C, Cange A, Neer RM, Kaplan LM, Finkelstein JS. Bone loss after bariatric surgery: discordant results between DXA and QCT bone density. J Bone Miner Res 2014;29:542-50.
73. Frederiksen KD, Hanson S, Hansen S, Brixen K, Gram J, Jørgensen NR, Støving RK. Bone structural changes and estimated strength after gastric bypass surgery evaluated by HR-pQCT. Calcif Tissue Int 2016;98:253-62.
74. Apovian CM, Aronne LJ, Bessesen DH, McDonnell ME, Murad MH, Pagotto U, Ryan DH, Still CD. Pharmacological management of obesity: an endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2015;100:342-62.
75. Tsigos C, Hainer V, Basdevant A, Finer N, Fried M, Mathus- Vliegen E, Micic D, Maislos M, Roman G, Schutz Y, Toplak H, Zahorska-Markiewicz B. Management of obesity in adults: European clinical practice guidelines. Obes Facts 2008;1:106-16.
76. National Health and Medical Research Council. Clinical practice guidelines for the management of overweight and obesity in adults, adolescents and children in Australia. Melbourne, 2013.
77. Fujioka K. Current and emerging medications for overweight or obesity in people with comorbidities. Diabetes Obes Metab 2015;17:1021-32.
78. Guerciolini R. Mode of action of orlistat. Int J Obes Relat Metab Disord 1997;21(Suppl 3):S12-23.
79. Gotfredsen A, Westergren Hendel H, Andersen T. Influence of orlistat on bone turnover and body composition. Int J Obes Relat Metab Disord 2001;25:1154-60.
80. Pace DG, Blotner S, Guerciolini R. Short-term orlistat treatment does not affect mineral balance and bone turnover in obese men. J Nutr 2001;131:1694-9.
81. Drucker DJ, Nauck MA. The incretin system: glucagon-like peptide- 1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. Lancet 2006;368:1696-705.
82. Blonde L, Klein EJ, Han J, Zhang B, Mac SM, Poon TH, Taylor KL, Trautmann ME, Kim DD, Kendall DM. Interim analysis of the effects of exenatide treatment on A1C, weight and cardiovascular risk factors over 82 weeks in 314 overweight patients with type 2 diabetes. Diabetes Obes Metab 2006;8:436-47.
83. Dushay J, Gao C, Gopalakrishnan GS, Crawley M, Mitten EK, Wilker E, Mullington J, Maratos-Flier E. Short-term exenatide treatment leads to significant weight loss in a subset of obese women without diabetes. Diabetes Care 2012;35:4-11.
84. Su B, Sheng H, Zhang M, Bu L, Yang P, Li L, Li F, Sheng C, Han Y, Qu S, Wang J. Risk of bone fractures associated with glucagon-like peptide-1 receptor agonists' treatment: a meta-analysis of randomized controlled trials. Endocrine 2015;48:107-15.
85. Mabilleau G, Mieczkowska A, Chappard D. Use of glucagon-like peptide-1 receptor agonists and bone fractures: a meta-analysis of randomized clinical trials. J Diabetes 2014;6:260-6.
86. Iepsen EW, Lundgren JR, Hartmann B, Pedersen O, Hansen T, Jorgensen NR, Jensen JE, Holst JJ, Madsbad S, Torekov SS. GLP-1 receptor agonist treatment increases bone formation and prevents bone loss in weight-reduced obese women. J Clin Endocrinol Metab 2015;100:2909-17.
87. Driessen JH, Henry RM, van Onzenoort HA, Lalmohamed A, Burden AM, Prieto-Alhambra D, Neef C, Leufkens HG, de Vries F. Bone fracture risk is not associated with the use of glucagon-like peptide-1 receptor agonists: a population-based cohort analysis. Calcif Tissue Int 2015;97:104-12.
88. Ravussin E, Redman LM, Rochon J, Das SK, Fontana L, Kraus WE, Romashkan S, Williamson DA, Meydani SN, Villareal DT, Smith SR, Stein RI, Scott TM, Stewart TM, Saltzman E, Klein S, Bhapkar M, Martin CK, Gilhooly CH, Holloszy JO, Hadley EC, Roberts SB. A 2-year randomized controlled trial of human caloric restriction: feasibility and effects on predictors of health span and longevity. J Gerontol A Biol Sci Med Sci 2015;70: 1097-104.
89. Villareal DT, Fontana L, Das SK, Redman L, Smith SR, Saltzman E, Bales C, Rochon J, Pieper C, Huang M, Lewis M, Schwartz AV, for the CSG. Effect of two-year caloric restriction on bone metabolism and bone mineral density in non-obese younger adults: a randomized clinical trial. J Bone Miner Res 2016;31:40-51.
90. Riedt CS, Schlussel Y, von Thun N, Ambia-Sobhan H, Stahl T, Field MP, Sherrell RM, Shapses SA. Premenopausal overweight women do not lose bone during moderate weight loss with adequate or higher calcium intake. Am J Clin Nutr 2007;85:972-80.
91. Redman LM, Rood J, Anton SD, Champagne C, Smith SR, Ravussin E, for the Pennington Comprehensive Assessment of Long-Term Effects of Reducing Intake of Energy Research T. Calorie restriction and bone health in young, overweight individuals. Arch Intern Med 2008;168:1859-66.
92. Shapses SA, Von Thun NL, Heymsfield SB, Ricci TA, Ospina M, Pierson RN, Stahl T. Bone turnover and density in obese premenopausal women during moderate weight loss and calcium supplementation. J Bone Miner Res 2001;16:1329-36.
93. Schafer AL. Decline in bone mass during weight loss: a cause for concern? J Bone Miner Res 2016;31:36-9.
94. Dixon JB, Lambert EA, Grima M, Rice T, Lambert GW, Straznicky NE. Fat-free mass loss generated with weight loss in overweight and obese adults: what may we expect? Diabetes Obes Metab 2015;17:91-3.
95. Villareal DT, Kotyk JJ, Armamento-Villareal RC, Kenguva V, Seaman P, Shahar A, Wald MJ, Kleerekoper M, Fontana L. Reduced bone mineral density is not associated with significantly reduced bone quality in men and women practicing long-term calorie restriction with adequate nutrition. Aging cell 2011;10:96-102.
96. Hinton PS, Rector RS, Linden MA, Warner SO, Dellsperger KC, Chockalingam A, Whaley-Connell AT, Liu Y, Thomas TR. Weight-loss-associated changes in bone mineral density and bone turnover after partial weight regain with or without aerobic exercise in obese women. Eur J Clin Nutr 2012;66:606-12.
97. Villalon KL, Gozansky WS, Van Pelt RE, Wolfe P, Jankowski CM, Schwartz RS, Kohrt WM. A losing battle: weight regain does not restore weight loss-induced bone loss in postmenopausal Women. Obesity (Silver Spring) 2011;19:2345-50.
98. Søgaard AJ, Meyer HE, Ahmed LA, Jørgensen L, Bjørnerem Å, Joakimsen RM, Emaus N. Does recalled dieting increase the risk of non-vertebral osteoporotic fractures? The Tromsø Study. Osteoporos Int 2012;23:2835-45.
99. Turner CH, Warden SJ, Bellido T, Plotkin LI, Kumar N, Jasiuk I, Danzig J, Robling AG. Mechanobiology of the skeleton. Sci Signal 2009;2:pt3.
100. Martyn-St James M, Carroll S. Effects of different impact exercise modalities on bone mineral density in premenopausal women: a meta-analysis. J Bone Miner Metab 2010;28:251-67.
101. Zhao R, Zhao M, Xu Z. The effects of differing resistance training modes on the preservation of bone mineral density in postmenopausal women: a meta-analysis. Osteoporos Int 2015;26:1605-18.
102. Martyn-St James M, Carroll S. A meta-analysis of impact exercise on postmenopausal bone loss: the case for mixed loading exercise programmes. Br J Sports Med 2009;43:898-908.
103. Shah K, Armamento-Villareal R, Parimi N, Chode S, Sinacore DR, Hilton TN, Napoli N, Qualls C, Villareal DT. Exercise training in obese older adults prevents increase in bone turnover and attenuates decrease in hip bone mineral density induced by weight loss despite decline in bone-active hormones. J Bone Miner Res 2011;26:2851-9.
104. Villareal DT, Fontana L, Weiss EP, Racette SB, Steger-May K, Schechtman KB, Klein S, Holloszy JO. Bone mineral density response to caloric restriction-induced weight loss or exerciseinduced weight loss: a randomized controlled trial. Arch Intern Med 2006;166:2502-10.
105. Robling AG, Niziolek PJ, Baldridge LA, Condon KW, Allen MR, Alam I, Mantila SM, Gluhak-Heinrich J, Bellido TM, Harris SE, Turner CH. Mechanical stimulation of bone in vivo reduces osteocyte expression of Sost/sclerostin. J Biol Chem 2008;283:5866-75.
106. Armamento-Villareal R, Sadler C, Napoli N, Shah K, Chode S, Sinacore DR, Qualls C, Villareal DT. Weight loss in obese older adults increases serum sclerostin and impairs hip geometry but both are prevented by exercise training. J Bone Miner Res 2012;27:1215-21.
107. Bal BS, Finelli FC, Shope TR, Koch TR. Nutritional deficiencies after bariatric surgery. Nat Rev Endocrinol 2012;8:544-56.
108. Sukumar D, Ambia-Sobhan H, Zurfluh R, Schlussel Y, Stahl TJ, Gordon CL, Shapses SA. Areal and volumetric bone mineral density and geometry at two levels of protein intake during caloric restriction: A randomized, controlled trial. J Bone Miner Res 2011;26:1339-48.
109. Mason C, Xiao L, Imayama I, Duggan C, Wang CY, Korde L, McTiernan A. Vitamin D3 supplementation during weight loss: a double-blind randomized controlled trial. Am J Clin Nutr 2014;99:1015-25.
110. Sainsbury A, Zhang L. Role of the hypothalamus in the neuroendocrine regulation of body weight and composition during energy deficit. Obes Rev 2012;13:234-57.
111. Folli F, Sabowitz BN, Schwesinger W, Fanti P, Guardado- Mendoza R, Muscogiuri G. Bariatric surgery and bone disease: from clinical perspective to molecular insights. Int J Obes (Lond) 2012;36:1373-9.
112. Orwoll ES, Oviatt SK, Mann T. The impact of osteophytic and vascular calcifications on vertebral mineral density measurements in men. J Clin Endocrinol Metab 1990;70:1202-7.
113. Masud T, Langley S, Wiltshire P, Doyle DV, Spector TD. Effect of spinal osteophytosis on bone mineral density measurements in vertebral osteoporosis. BMJ 1993;307:172-3.
114. Selby PL, McCloskey EV, Robinson J, Smith IG, Potts B, Beneton MN, Kanis JA. Is a calculated total hip BMD of clinical use? Osteoporos Int 2000;11:368-71.
115. Salis (nee Sainsbury) A. Sub-study of the PREVIEW study Australia: effects of weight loss on appetite, bone mass and muscle strength. Clinical Trial: NCT 0203 0249 [Internet] Sydney (Australia): ClinicalTrials.gov; 2013 [cited 2016 July 20]. Available from: https://clinicaltrials.gov/ct2/show/study/ NCT02030249.
116. Sainsbury-Salis A, Byrne NM, Caterson ID. Long-term effects of very low energy diet versus conventional diet on adiposity, lean body mass, muscle strength and bone density in obese adults (postmenopausal women), and mechanisms promoting changes (the TEMPO Diet Trial: Type of Energy Manipulation for Promoting optimum metabolic health and body composition in Obesity). ACTRN 12612000651886 [Internet] Sydney (Australia): Australian New Zealand Clinical Trials Registry (ANZCTR); 2012 [cited 2016 July 20]. Available from: https://http://www.anzctr.org.au/Trial/ Registration/TrialReview.aspx?ACTRN=12612000651886.
117. Cefalu WT, Bray GA, Home PD, Garvey WT, Klein S, Pi-Sunyer FX, Hu FB, Raz I, Van Gaal L, Wolfe BM, Ryan DH. Advances in the science, treatment, and prevention of the disease of obesity: reflections from a diabetes care editors' expert forum. Diabetes Care 2015;38:1567-82.